Related references
Note: Only part of the references are listed.Prevalence of 5-Lipoxygenase Expression in Canine Osteosarcoma and the Effects of a Dual 5-Lipoxygenase/Cyclooxygenase Inhibitor on Osteosarcoma Cells In Vitro and In Vivo
R. C. Goupil et al.
VETERINARY PATHOLOGY (2012)
A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations
Andrea Y. Angstadt et al.
CANCER GENETICS (2012)
5-Lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats
Joseph J. Wakshlag et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2011)
Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors
Xiaoling Ding et al.
BIOMEDICINE & PHARMACOTHERAPY (2011)
Cyclooxygenases and lipoxygenases in cancer
Claus Schneider et al.
CANCER AND METASTASIS REVIEWS (2011)
Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer
Naveena B. Janakiram et al.
CANCER AND METASTASIS REVIEWS (2011)
Cyclooxygenase- and lipoxygenase-mediated DNA damage
N. Speed et al.
CANCER AND METASTASIS REVIEWS (2011)
Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma
Shi Hai-yun et al.
CANCER LETTERS (2011)
Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2011)
Chemopreventive Efficacy and Mechanism of Licofelone in a Mouse Lung Tumor Model via Aspiration
Sheela Sharma et al.
CANCER PREVENTION RESEARCH (2011)
Characterization of Canine Osteosarcoma by Array Comparative Genomic Hybridization and RT-qPCR: Signatures of Genomic Imbalance in Canine Osteosarcoma Parallel the Human Counterpart
Andrea Y. Angstadt et al.
GENES CHROMOSOMES & CANCER (2011)
Regulation of inflammation in cancer by eicosanoids
Emily R. Greene et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft
J. L. Sottnik et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Alkylation of the Tumor Suppressor PTEN Activates Akt and β-Catenin Signaling: A Mechanism Linking Inflammation and Oxidative Stress with Cancer
Tracy M. Covey et al.
PLOS ONE (2010)
Comparison of tepoxalin, carprofen, and meloxicam for reducing intraocular inflammation in dogs
Margi A. Gilmour et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2009)
Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
Melissa Paoloni et al.
BMC GENOMICS (2009)
Dual LOX/COX inhibitors: potential novel anti-cancer drugs
R. Vijayakrishnan
IRISH JOURNAL OF MEDICAL SCIENCE (2009)
Effects of Firocoxib and Tepoxalin on Healing in a Canine Gastric Mucosal Injury Model
L. Goodman et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study
Christa Horvath-Ungerboeck et al.
VETERINARY DERMATOLOGY (2009)
Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs
John P. Punke et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2008)
Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade
Simona Tavolari et al.
CARCINOGENESIS (2008)
Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor
T. M. Covey et al.
ONCOGENE (2007)
Dual acting anti-inflammatory drugs
S. Leone et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
COX-2/5-LOX dual acting anti-inflammatory drugs in cancer chemotherapy
Laurence Goossens et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Interaction of free fatty acids with mitochondria: Coupling, uncoupling and penneability transition
Marco Di Paola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells
Toyohide Hayashi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
MK-886 enhances tumour necrosis factor-α-induced differentiation and apoptosis
Jiri Stika et al.
CANCER LETTERS (2006)
Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells
B Wolfesberger et al.
RESEARCH IN VETERINARY SCIENCE (2006)
In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells
B Wolfesberger et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2006)
Effects of tissue transglutaminase on beta-amyloid(1-42)-induced apoptosis
Joseph J. Wakshlag et al.
PROTEIN JOURNAL (2006)
The in vitro effects of piroxicam and meloxicam on canine cell lines
C Knottenbelt et al.
JOURNAL OF SMALL ANIMAL PRACTICE (2006)
Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs
SR Royals et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2005)
Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L
JB Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vivo effects of tepoxalin, an inhibitor of cyclooxygenase and lipoxygenase, on prostanoid and leukotriene production in dogs with chronic osteoarthritis
KA Agnello et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2005)
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
YN Ye et al.
CARCINOGENESIS (2005)
Disparate forms of MK 886-induced programmed death in BCL-2(+) blood and BCL-2(-) solid cancer cells and a putative nuclear Ca2+ channel: soil trumps seed?
KM Anderson et al.
MEDICAL HYPOTHESES (2005)
New COX-2/5-LOX inhibitors:: Apoptosis-inducing agents potentially useful in prostate cancer chemotherapy
N Pommery et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer
SI Mohammed et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors
RA Levine et al.
VETERINARY PATHOLOGY (2002)
New trends in dual 5-LOX/COX inhibition
X de Leval et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Share Paper
